Provided herein are inhibitors of TNFα, pharmaceutical compositions comprising the inhibitory compounds, and methods for using the TNFα inhibitory compounds for the treatment of diseases or disorders.
[EN] PROTEIN TYROSINE PHOSPHATASE INHIBITORS AND METHODS OF USE THEREOF<br/>[FR] INHIBITEURS DE PROTÉINE TYROSINE PHOSPHATASE ET LEURS MÉTHODES D'UTILISATION
申请人:CALICO LIFE SCIENCES LLC
公开号:WO2021127499A1
公开(公告)日:2021-06-24
Provided herein are compounds, compositions, and methods useful for inhibiting protein tyrosine phosphatase, e.g, protein tyrosine phosphatase non-receptor type 2 (PTPN2) and/or protein tyrosine phosphatase non-receptor type 1 (PTPN1), and for treating related diseases, disorders and conditions favorably responsive to PTPN1 or PTPN2 inhibitor treatment, e.g, a cancer or a metabolic disease.
Kleiner,H.-J., Justus Liebigs Annalen der Chemie, 1974, p. 751 - 764
作者:Kleiner,H.-J.
DOI:——
日期:——
SOEDER A.; PERREY K., POL. J. CHEM., 1980, 54, NO 6, 1305-1311
作者:SOEDER A.、 PERREY K.
DOI:——
日期:——
Process for the preparation of tertiary phosphine oxides
申请人:Hoechst Aktiengesellschaft
公开号:US04056571A1
公开(公告)日:1977-11-01
Tertiary phosphine oxides are obtained by adding olefins having a terminal hydroxy or amino group or functional derivatives thereof to secondary phosphine oxides. The adducts are useful as intermediates in the preparation of flame-retardant agents, anti-corrosive agents, pesticides, pharmaceuticals and detergents.